BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6803619)

  • 1. Lysates of turkey-grown Pasteurella multocida: protection against homologous and heterologous serotype challenge exposures.
    Rimler RB; Rhoades KR
    Am J Vet Res; 1981 Dec; 42(12):2117-21. PubMed ID: 6803619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysates of turkey-grown Pasteurella multocida: effects of solubilizing agents on the immunologic properties of membrane vesicles.
    Brogden KA; Rimler RB
    Am J Vet Res; 1983 Mar; 44(3):428-32. PubMed ID: 6838037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysates of turkey-grown Pasteurella multocida: examination of vaccine preparations by electron microscopy.
    Brogden KA; Rimler RB
    Am J Vet Res; 1982 Feb; 43(2):304-9. PubMed ID: 7046537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysates of turkey-grown Pasteurella multocida: partial solubilization of the cross-protection factor(s).
    Brogden KA; Rimler RB
    Am J Vet Res; 1982 Oct; 43(10):1781-5. PubMed ID: 7149376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection factor(s) of Pasteurella multocida: passive immunization of turkeys against fowl cholera caused by different serotypes.
    Rimler RB
    Avian Dis; 1987; 31(4):884-7. PubMed ID: 3442539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fowl cholera: cross-protection induced by Pasteurella multocida separated from infected turkey blood.
    Rimler RB; Rebers PA; Rhoades KR
    Avian Dis; 1979; 23(3):730-41. PubMed ID: 526205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(4):975-85. PubMed ID: 1485881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
    Wang C; Glisson JR
    Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium.
    Glisson JR; Contreras MD; Cheng IH; Wang C
    Avian Dis; 1993; 37(4):1074-9. PubMed ID: 8141736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fowl cholera: induction of cross-protection in turkeys with bacterins prepared from host-passaged Pasteurella multocida.
    Rebers PA; Heddleston KL
    Avian Dis; 1977; 21(1):50-6. PubMed ID: 843303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated live fowl cholera vaccine. I. Development of vaccine strain M3G of Pasteurella multocida.
    Hertman I; Markenson J; Michael A; Geier E
    Avian Dis; 1979; 23(4):863-9. PubMed ID: 546409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a streptomycin dependent live Pasteurella multocida vaccine in rabbits.
    DiGiacomo RF; Deeb BJ; Bernard BL; Klaassen JM; Chengappa MM
    Lab Anim Sci; 1987 Apr; 37(2):187-90. PubMed ID: 3599888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity and vaccine development in Pasteurella multocida infections.
    Adler B; Chancellor R; Homchampa P; Hunt M; Ruffolo C; Strugnell R; Wapling D
    J Biotechnol; 1996 Jan; 44(1-3):139-44. PubMed ID: 8717397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection and antigen expression by chicken embryo-grown Pasteurella multocida in chickens.
    Ibrahim RS; Sawada T; Shahata M; Ibrahim A
    J Comp Pathol; 2000 Nov; 123(4):278-84. PubMed ID: 11041997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural location of the cross-protection factor on in vivo and in vitro grown Pasteurella multocida.
    Rimler RB; Brogden KA
    Avian Dis; 2001; 45(4):946-52. PubMed ID: 11785898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of membrane-associated cross-protection factor(s) of Pasteurella multocida.
    Rimler RB; Rhoades KR
    Avian Dis; 1989; 33(2):258-63. PubMed ID: 2751557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
    Chung JY; Wilkie I; Boyce JD; Adler B
    Vaccine; 2005 Apr; 23(21):2751-5. PubMed ID: 15780722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection by a chemically altered vaccinal strain of Pasteurella multocida in mice and hamsters.
    Wong JC; Kucera CJ
    Am J Vet Res; 1982 Jul; 43(7):1315-6. PubMed ID: 7103214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A streptomycin-dependent live pasteurella multocida type-3 vaccine for the prevention of fowl cholera in turkeys.
    Chengappa MM; Carter GR; Chang TS
    Avian Dis; 1979; 23(1):57-61. PubMed ID: 486008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.